Asthma Controller & Rescue Therapy from Multiple manufacturers.
Inhaled and nebulized therapies form the backbone of asthma management at every level of severity. Selection is based on asthma severity, exacerbation history, lung function, biomarkers, and response to prior treatment. Categories include inhaled corticosteroids (ICS) such as Arnuity, ICS-LABA combinations such as Advair, Wixela, Breo, and Breyna, ICS-LABA-LAMA combinations such as Trelegy, short-acting beta-agonists (SABA) such as albuterol, and newer anti-inflammatory rescue inhalers such as Airsupra (albuterol-budesonide). Nebulized therapies are used in selected patients. Inhaler therapy is optimized in parallel with — not replaced by — biologic therapy when biologics are appropriate.
Asthma Inhaler & Nebulizer Therapy is FDA-approved for the following indications:
Inhaled therapies require correct inhaler technique to be effective. Optimed Immunology reviews inhaler technique at every visit and adjusts the regimen based on symptoms, lung function, and exacerbation pattern. Nebulizer therapy is added or substituted when appropriate.
The manufacturer offers a patient support program — Varies by product; manufacturer copay programs available for branded inhalers — that can help with insurance navigation, copay assistance for eligible patients, nursing support, and ongoing education. More information is available at https://www.fda.gov.
Treatment with Asthma Inhaler & Nebulizer Therapy is initiated and monitored by Dr. McNeil. Prior authorizations are handled in-house — patients are not asked to navigate insurance approvals on their own. Inhaler regimens are individualized to your asthma severity and response. The team prescribes both controller and rescue inhalers, reviews technique at every visit, and adjusts therapy based on symptoms, lung function, and exacerbation pattern. Specific brand selection is often driven by insurance formulary; the team handles substitutions and prior authorizations as needed.
Important safety note: This page is not a substitute for the FDA prescribing information. Risks, contraindications, drug interactions, and required monitoring vary by patient. The official manufacturer website (https://www.fda.gov) provides the most current full prescribing and safety information. Treatment decisions and monitoring are individualized — please discuss with Dr. McNeil whether Asthma Inhaler & Nebulizer Therapy is appropriate for your situation.
Donald L. McNeil, MD · Board Certified in Allergy & Immunology and Internal Medicine
This page is provided for educational purposes only and is not medical advice. If you have an emergency, call 911.